- Report
- March 2023
- 116 Pages
Global
From €4011EUR$4,500USD£3,523GBP
- Report
- December 2022
- 117 Pages
Global
From €4011EUR$4,500USD£3,523GBP
- Report
- August 2022
- 118 Pages
Global
From €4011EUR$4,500USD£3,523GBP
- Report
- October 2021
- 111 Pages
Global
From €4011EUR$4,500USD£3,523GBP
- Report
- July 2025
- 200 Pages
Saudi Arabia
From €2486EUR$2,789USD£2,184GBP
- Report
- June 2025
- 250 Pages
Germany
From €2486EUR$2,789USD£2,184GBP
- Report
- June 2025
- 400 Pages
Qatar
From €2486EUR$2,789USD£2,184GBP
- Report
- September 2024
- 150 Pages
Mexico
From €3208EUR$3,599USD£2,818GBP
- Report
- September 2024
- 150 Pages
Latin America
From €3449EUR$3,869USD£3,029GBP
- Report
- September 2024
- 150 Pages
Europe
From €3449EUR$3,869USD£3,029GBP
- Report
- September 2024
- 150 Pages
Asia Pacific
From €3449EUR$3,869USD£3,029GBP
- Report
- September 2024
- 150 Pages
Africa, Middle East
From €3449EUR$3,869USD£3,029GBP
- Report
- September 2024
- 150 Pages
North America
From €3449EUR$3,869USD£3,029GBP
- Report
- August 2024
- 200 Pages
Global
From €4411EUR$4,949USD£3,875GBP
- Report
- August 2024
- 200 Pages
Global
From €4411EUR$4,949USD£3,875GBP
- Report
- August 2024
- 180 Pages
North America
From €3449EUR$3,869USD£3,029GBP
- Report
- August 2024
- 200 Pages
Global
From €4411EUR$4,949USD£3,875GBP
- Report
- June 2024
- 140 Pages
Middle East, Africa
From €3449EUR$3,869USD£3,029GBP
- Report
- April 2024
- 140 Pages
Global
From €4411EUR$4,949USD£3,875GBP
From €2486EUR$2,789USD£2,184GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more